Financial Impact of Hidradenitis Suppurativa in Spain

1

Hidradenitis suppurativa (HS) imposes an average annual cost of €39,535.10 per patient in Spain, highlighting its significant economic burden.
2

The study indicates that informal caregiving expenses are a major contributor to the overall costs associated with HS.
3

HS severely impacts patients' quality of life, leading to psychological issues such as depression and anxiety, which further complicate their condition.
4

Only 10% of HS patients in Spain receive an accurate diagnosis, resulting in significant delays that allow disease progression.
5

The findings underscore the necessity for early diagnosis and treatment to mitigate the economic impact and enhance patients' quality of life.

Dermatology And Therapy (Springer)

by Eva Vilarrasa, Joaquín Borrás-Blasco, Silvia Lobo-Benito, Marta Loro-Pérez, Marta Garcia Núñez-García, Juan Oliva-Moreno, David Palacios-Martínez, Félix Rubial-Bernárdez, Yoana Ivanova-Markova, Mathilde Daheron, Javier Bellas, Antonio Martorell
February 22, 2026

1